Viewing Study NCT02689869


Ignite Creation Date: 2025-12-24 @ 10:47 PM
Ignite Modification Date: 2026-01-28 @ 1:54 PM
Study NCT ID: NCT02689869
Status: UNKNOWN
Last Update Posted: 2021-05-07
First Post: 2016-02-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination of PCI-32765 With Obinutuzumab in Untreated Follicular Lymphoma
Sponsor: Ludwig-Maximilians - University of Munich
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Indolent Non-Hodgkin Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None indolent lymphoma View
None novel agents View
None chemotherapy free treatment View
None ibrutinib View
None obinutuzumab View
None GA101 View